等待开盘 09-27 09:30:00 美东时间
-0.350
-1.19%
今日重点评级关注:Maxim Group:维持T Stamp"买入"评级,目标价从8美元升至12美元;Maxim Group:维持Rezolute"买入"评级,目标价从15美元升至20美元
09-22 18:44
In the preceding three months, 11 analysts have released ratings for Sportradar...
09-20 03:02
今日重点评级关注:HC Wainwright & Co.:维持Immix Biopharma"买入"评级,目标价从7美元升至8美元;Maxim Group:上调CNS Pharma评级至"买入",目标价20美元
09-15 11:13
Roth Capital analyst Eric Handler initiates coverage on Sportradar Gr (NASDAQ:SRAD) with a Buy rating and announces Price Target of $40.
09-13 01:36
JMP Securities analyst Jordan Bender maintains Sportradar Gr (NASDAQ:SRAD) with a Market Outperform and raises the price target from $30 to $36.
09-03 21:26
Sportradar and Bundesliga International are expanding their partnership to enhance fan engagement through advanced data and AI-driven innovations. The collaboration introduces Live Player Markets, 4Sight Streaming, and Enhanced Live Match Trackers for the 2025-26 Bundesliga season, offering richer viewing and betting experiences.
08-19 10:00
9 analysts have shared their evaluations of Sportradar Gr (NASDAQ:SRAD) during ...
08-15 03:00
UBS analyst Robin Farley maintains Sportradar Gr (NASDAQ:SRAD) with a Buy and raises the price target from $29 to $39.
08-14 22:44
在最新的第二季度业绩中,博彩行业的表现呈现出明显的分化。
08-12 16:50
今日重点评级关注:韦德布什:维持Gossamer Bio"跑赢大市"评级,目标价从4美元升至5美元;HC Wainwright & Co.:维持EyePoint Pharmaceuticals"买入"评级,目标价从22美元升至23美元
08-07 09:46